Top Markets
Coin of the day
Medesis Pharma S.A. Medesis Pharma S.A.

Medesis Pharma S.A.

ALMDP
Kedudukan dalam Saham #37493
Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development... Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments. The company's pipeline features several innovative compounds, including NanoLithium (NP03), which is currently undergoing clinical trials for Alzheimer's disease, and NanosiRNA DH, targeting Huntington's Disease. Medesis Pharma also develops NU01 Plutonium and NU02 Cesium for nuclear decorporation, alongside NP02 – NanoManganese, a radioprotection medication designed for individuals exposed to radiation from nuclear incidents. Furthermore, their portfolio encompasses NanosiRNA COVID-19, an antiviral solution for various viral infections, and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for oncological applications. Established in 2003, the enterprise operates from its headquarters in Montpellier, France.
Harga Saham
$0.38207938
Disegerakkan terakhir: 2025-04-07
Modal Pasaran
$1.67M
Perubahan (1 hari)
-0.39%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Medesis Pharma S.A. (ALMDP)

Kategori

Sejarah harga saham bagi Medesis Pharma S.A. (ALMDP)
Harga penutupan tertinggi: $0.38 pada 2025-04-01

Harga penutupan terendah: $15.89 pada 2021-02-01
Sejarah harga saham Medesis Pharma S.A. dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2025 7.86%
2024 -63.03%
2023 -54.06%
2022 -64.90%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE